Stryker debuted its Stryker Challenge at the PGA Tour's Shell Houston Open in Humble, Texas, according to pharmiweb.com.
Spinal Tech
Alpharetta, Ga.-based SANUWAVE Health received a U.S. patent called "Increase Electrode Life in Devices Used for Extracorporeal Shockwave Therapy."
InVivo Therapeutics' neuro-spinal scaffold device is designed to reduce paralysis symptoms resulting from acute spinal cord injury, according to MoneyShow.
Belgium-based Bone Therapeutics reported the 12-month efficacy results from the PREOB Phase IIA severe osteoporosis trial.
BioPoly received the CE mark for its BioPoly RS Partial Resurfacing Shoulder System.
Stryker Director Ronda E. Stryker sold 12,000 shares of the company's stock in a recent transaction, according to a South Florida Hedge Fund Managers report.
Amedica shares fell 12.95 percent in short interest, according to Clinton Financial.
During the fourth quarter, Segall Bryant Hamill bought up to 16,097 Orthofix International shares, according to Street Edition.
Melbourne, Australia-based ARC Center of Excellence for Electromaterials Science researchers developed a biopen for stem cell therapy, according to Forbes.
NuVasive's short interest saw an increase of 26.2 percent between Feb. 29 and March 15, according to a Financial Market News report.
